Efficacy of adding teriparatide versus switching to teriparatide in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate

被引：0
|
作者：
Cosman, F. [1 ]
Wermers, R. A. [2 ]
Recknor, C. [3 ]
Mauck, K. F. [2 ]
Xie, L. [4 ]
Glass, E. V. [4 ]
Krege, J. H. [4 ]
机构：
[1] Helen Hayes Hosp, Clin Res Ctr, W Haverstraw, NY USA
[2] Mayo Clin, Rochester, MN 55905 USA
[3] United Osteoporosis Ctr, Gainesville, FL 32601 USA
[4] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
CALCIFIED TISSUE INTERNATIONAL | 2008年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S59 / S60
页数：2
相关论文
共 50 条
  • [41] Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis A meta-analysis of randomized controlled trials
    Wang, Ya-Kang
    Qin, Si-Qing
    Ma, Tao
    Song, Wei
    Jiang, Ren-Qi
    Guo, Jian-Bin
    Li, Kun
    Zhang, Yu-Min
    [J]. MEDICINE, 2017, 96 (21)
  • [42] Vertebral and Femoral Strength Increased In Postmenopausal Women with Osteoporosis Treated with Teriparatide for 18 Months
    Keaveny, Tony M.
    Maricic, Michael
    Kopperdahl, David
    Ruff, Valerie
    Wan, Xiaohai
    Krohn, Kelly
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S429 - S429
  • [43] EFFECTS OF TERIPARATIDE ON VERTEBRAL BODY BIOMECHANICS IN POSTMENOPAUSAL WOMEN TREATED PREVIOUSLY WITH RISEDRONATE OR ALENDRONATE: A QCT-BASED FINITE ELEMENT STUDY
    Zysset, P.
    Quek, E.
    Borah, B.
    Gross, G.
    Stewart, J.
    Lang, T.
    Chevalier, Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 154 - 154
  • [44] Effect of Teriparatide Versus Zoledronate on Posterior Lumbar Interbody Fusion in Postmenopausal Women with Osteoporosis
    Xiong, Yu
    Li, Liang
    Liu, Ping
    Zhou, Bin
    Kang, Yijun
    Wang, Guoqiang
    [J]. WORLD NEUROSURGERY, 2022, 167 : E1310 - E1316
  • [45] The cost-effectiveness of therapy with Teriparatide and alendronate in women with severe osteoporosis
    Liu, Hau
    Michaud, Kaleb
    Nayak, Smita
    Karpf, David B.
    Owens, Douglas K.
    Garber, Alan M.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (11) : 1209 - 1217
  • [46] Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis
    Debiais, F
    [J]. JOINT BONE SPINE, 2003, 70 (06) : 465 - 470
  • [47] Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate
    Gamsjaeger, Sonja
    Buchinger, Birgit
    Zoehrer, Ruth
    Phipps, Roger
    Klaushofer, Klaus
    Paschalis, Eleftherios P.
    [J]. BONE, 2011, 49 (06) : 1160 - 1165
  • [48] Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate
    Miller, Paul D.
    Delmas, Pierre D.
    Lindsay, Robert
    Watts, Nelson B.
    Luckey, Marjorie
    Adachi, Jonathan
    Saag, Kenneth
    Greenspan, Susan L.
    Seeman, Ego
    Boonen, Steven
    Meeves, Suzanne
    Lang, Thomas F.
    Bilezikian, John P.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10): : 3785 - 3793
  • [49] Daily or Cyclical Teriparatide Treatment in Women With Osteoporosis on no Prior Therapy and Women on Alendronate
    Cosman, Felicia
    Nieves, Jeri W.
    Zion, Marsha
    Garrett, Patricia
    Neubort, Simon
    Dempster, David
    Lindsay, Robert
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (07): : 2769 - 2776
  • [50] Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment
    P. D. Miller
    E. N. Schwartz
    P. Chen
    D. A. Misurski
    J. H. Krege
    [J]. Osteoporosis International, 2007, 18 : 59 - 68
12345